• Cytokinetics (NASDAQ:CYTK) Receives Buy Rating from HC Wainwright

    Source: Buzz FX / 10 Jan 2025 08:03:15   America/Chicago


    Cytokinetics (NASDAQ:CYTK) Receives Buy Rating from HC Wainwright Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "buy" rating reaffirmed by stock analys
    Read more...
Share on,